Antimicrobial Advertising Guidance Should Target Resistance - FDA Group
Executive Summary
An FDA guidance on direct-to-consumer advertising of antimicrobials should address resistance issues, an agency-wide task force report suggests.
You may also be interested in...
Drug Makers Face Higher Relabeling Burden For Antibacterial Resistance Info
FDA plans to issue a yearly update on the susceptibility of bacteria to treatment by individual antibiotics and has drafted guidance that calls on drug makers to revise labeling for systemic antibacterial products accordingly
Drug Makers Face Higher Relabeling Burden For Antibacterial Resistance Info
FDA plans to issue a yearly update on the susceptibility of bacteria to treatment by individual antibiotics and has drafted guidance that calls on drug makers to revise labeling for systemic antibacterial products accordingly
Pfizer Zithromax Settlement Signals More State Drug Advertising Oversight
Pfizer's $6 mil. Zithromax settlement with 19 state attorneys general over promotions for the antibiotic signals an increase in state oversight of drug promotional practices